These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30324703

  • 1. Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
    Shafuddin E, Chang CL, Cooray M, McAnulty KA, Karalus NC, Lee MHS, Hancox RJ.
    Intern Med J; 2019 Jun; 49(6):761-769. PubMed ID: 30324703
    [Abstract] [Full Text] [Related]

  • 2. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E, Chang CL, Cooray M, Tuffery CM, Hopping SJ, Sullivan GD, Jacobson GA, Hancox RJ.
    Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
    [Abstract] [Full Text] [Related]

  • 3. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, Hancox RJ.
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [Abstract] [Full Text] [Related]

  • 4. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Hamda KB, Amor AB, Najjar MF, Knani J.
    Am J Respir Crit Care Med; 2006 Nov 01; 174(9):990-6. PubMed ID: 16840745
    [Abstract] [Full Text] [Related]

  • 5. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G.
    Eur J Intern Med; 2019 Feb 01; 60():46-53. PubMed ID: 30366614
    [Abstract] [Full Text] [Related]

  • 6. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I, Jalloul F, Ayed S, Dachraoui F, Ouanes-Besbes L, Fekih Hassen M, Elatrous S, Abroug F.
    Respirology; 2012 May 01; 17(4):660-6. PubMed ID: 22348741
    [Abstract] [Full Text] [Related]

  • 7. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I, Milutinov S, Lozanov Crvenkovic Z, Matijasevic J, Andrijevic A, Kovacevic T, Bokan D, Zaric B.
    Lung; 2018 Oct 01; 196(5):583-590. PubMed ID: 29951921
    [Abstract] [Full Text] [Related]

  • 8. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM, Chen V, Hollander Z, Hague CJ, Murphy DT, Leipsic JA, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD.
    Int J Chron Obstruct Pulmon Dis; 2018 Oct 01; 13():217-229. PubMed ID: 29386890
    [Abstract] [Full Text] [Related]

  • 9. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D.
    J Vasc Surg; 2009 Feb 01; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [Abstract] [Full Text] [Related]

  • 10. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.
    Chang CL, Mills GD, Karalus NC, Jennings LC, Laing R, Murdoch DR, Chambers ST, Vettise D, Tuffery CM, Hancox RJ.
    PLoS One; 2013 Feb 01; 8(5):e62612. PubMed ID: 23667500
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
    Choi HS, Kim KH, Yoon HJ, Hong YJ, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC, Kang JC.
    J Cardiol; 2012 Dec 01; 60(6):508-13. PubMed ID: 22902901
    [Abstract] [Full Text] [Related]

  • 12. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
    Grasso S, Leone A, De Michele M, Anaclerio R, Cafarelli A, Ancona G, Stripoli T, Bruno F, Pugliese P, Dambrosio M, Dalfino L, Di Serio F, Fiore T.
    Crit Care Med; 2007 Jan 01; 35(1):96-105. PubMed ID: 17095948
    [Abstract] [Full Text] [Related]

  • 13. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M, Duma A, Helwani MA, Brown J, Brown F, Gage BF, Gibson DW, Miller JP, Novak E, Jaffe AS, Apple FS, Scott MG, Nagele P.
    Anesth Analg; 2017 Feb 01; 124(2):398-405. PubMed ID: 28002165
    [Abstract] [Full Text] [Related]

  • 14. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease.
    Marcun R, Sustic A, Brguljan PM, Kadivec S, Farkas J, Kosnik M, Coats AJ, Anker SD, Lainscak M.
    Int J Cardiol; 2012 Nov 29; 161(3):156-9. PubMed ID: 22668800
    [Abstract] [Full Text] [Related]

  • 15. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH, Camargo CA, Krauser D, Anwaruddin S, Baggish A, Chen A, Januzzi JL.
    Ann Emerg Med; 2006 Jul 29; 48(1):66-74. PubMed ID: 16781921
    [Abstract] [Full Text] [Related]

  • 16. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS.
    Eur J Heart Fail; 2012 Dec 29; 14(12):1338-47. PubMed ID: 22869458
    [Abstract] [Full Text] [Related]

  • 17. Cardiac dysfunction and N-terminal pro-B-type natriuretic peptide in exacerbations of chronic obstructive pulmonary disease.
    Lee MH, Chang CL, Davies AR, Davis M, Hancox RJ.
    Intern Med J; 2013 May 29; 43(5):595-8. PubMed ID: 23668272
    [Abstract] [Full Text] [Related]

  • 18. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS, Murakami MM, Pearce LA, Herzog CA.
    Clin Chem; 2004 Dec 29; 50(12):2279-85. PubMed ID: 15364888
    [Abstract] [Full Text] [Related]

  • 19. Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms.
    Wieshammer S, Dreyhaupt J, Müller D, Momm F, Jakob A.
    Oncology; 2016 Dec 29; 90(3):143-50. PubMed ID: 26871423
    [Abstract] [Full Text] [Related]

  • 20. Right ventricular dysfunction in acute pulmonary embolism: NT-proBNP vs. troponin T.
    Cotugno M, Orgaz-Molina J, Rosa-Salazar V, Guirado-Torrecillas L, García-Pérez B.
    Med Clin (Barc); 2017 Apr 21; 148(8):339-344. PubMed ID: 28131517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.